Sie sind auf Seite 1von 3

NUTRITIONAL MANAGEMENT OF follows intensive therapy for respiratory

PULMONARY DISEASE difficulties in the neonatal period


Lec by: Dr. R.C. Laygo
_______________________________________ Assessment:
 Linear growth
Inadequate energy intake:  Dietary intake
 Weight loss-poor prognosis  GER
 Malnutrition-impaired immunity  Chronic hypoxia
 Length of hospital stay- ↑ morbidity,  Emotional deprivation
mortality
Goals of nutritional care:
Adverse Effects of Lung Diseases on Nutritional  Adequate nutrient intake
Status:  Promote linear growth
 Increase energy expenditure  Develop age appropriate feeding skills
1. ↑ work of breathing  Maintain fluid balance
2. chronic infection
3. medical treatments Energy
(bronchodilator, chest physical Resting Energy Expenditure
therapy)  25-50% greater than that in age matched
 decrease intake controls
1. fluid resuscitation Energy needs vary:
2. shortness of breath  Acute phase 50-85 kcal/kg daily
3. ↓ O2 saturation when eating  Convalescent phase 120-130 kcal/kg or
4. anorexia due to chronic disease more daily
5. GI distress & vomiting
 Additional limitations Macronutrients
1. difficulty preparing food due to  CHON should provide 7% or more of
fatigue total calories
2. lack of financial resources  Additional fat or CHO-made after
3. impaired feeding skills (infants formula has been concentrated to 24
& children) kcal/oz
4. altered metabolism
Maintenance of fluid balance
Herbal remedies:  Fluid restriction
 Cough suppressants  Na restriction
1. volatile oil of eucalyptus  Long term treatment with diuretics
2. peppermint teas
3. lagundi Vitamins & minerals
 expectorants  Vit. ACEK
1. anise  Inositol
2. fennel  FFA
3. thyme
 Selenium
Integral components of Care for patients with
L-glunolactone oxidase-enzyme for Vit C
pulmonary system disease
metabolism
 nutritional assessment
 intervention Important for:
 counseling Hydroxylation of proline→hydroxyproline,
lysine→hydroxylysine for the cross linkage of
Impact of Malnutrition collagen
 ↓ vital capacity (lung volume)
 ↓ minute ventilation (volume Feeding Strategies
exhaled/minute) To meet energy needs:
 ↓ efficiency of ventilation  Calorically dense formulas
 ↑ compliance (dispensability)  Small, frequent feedings
 ↑ elasticity  Use of soft nipple
 ↑ surfactant  NGT or gastrostomy tube feedings
(dipalmitoylphosphatidylcholine) GER
 Thickened feedings
Pulmonary edema (½ to 1 tbsp of infant cereal is
-↓ O2 transport, respiratory muscle strength, added per ounce of formula)
energy substrate in the cell, ventilatory drive  Upright positioning
with hypoxia, immune function
 Medications: antacids, H2 receptor
antagonists
Bronchopulmonary dysplasia-chronic lung
disorder seen in early infancy and usually
Cystic Fibrosis
 inherited autosomal recessive disorder  pancreatic enzyme replacement
 Epithelial cells and exocrine glands  adjust macronutrient for symptoms
secrete abnormal mucus (thick)  nutrients for growth
 Affects respiratory tract, sweat, salivary,  meconium ileus equivalent: intestinal
intestine, pancreas, liver, reproductive obstruction (enzyme, fiber, fluids,
tract exercise, stool softeners)

Diagnosis Nutrient Needs


 Neonatal screening provides Vitamins
opportunity to prevent  water soluble vitamins need not be ↑
 malnutrition in CF patients (exception may be B12)
 sweat test (Na & Cl >60 mEq/L)  fat soluble (may need supplement)
 chronic lung disease  Na-infants need ⅛ to ¼ tsp/day added
 failure to thrive salt
 malabsorption
 family history Medical Nutrition Therapy
↑ energy intake
Nutritional Assessment  Serving size
List of important assessment points  Snacks
Significant findings:  ↑ calorie foods
 recent weight loss or <90% BW  Supplements
 Is weight fluid or adipose or LBM?  Night gastrostomy tube feeding with
 Indirect calorimetry enzyme
 Edema lowers total protein & albumin  TPN only when GI not usable, or in
Anthropometry advanced CF (monitor risks of sepsis)
 Weight
 Height (≥ 2 yo), length (< 2 yo) COPD-obstruction of airways
 Head circumference  Bronchospasm-asthma
 Mid-arm circumference  Overproduction of mucus-bronchitis
 Triceps skinfold thickness  Destruction of elastin-emphysema
 Obstruction-bronchoectasis
Nutritional Assessment  Right sided heart failure-cor pulmonale
 Dietary intake
 3 D fat balance Emphysema Chronic Bronchitis
 Anticipatory dietary guidance Thin, cachetic, older Normal weight (often overweight)
Hypoxemia-mild Hypoxemia-prominent
Lab studies Normal Hct Increased Hct
 CBC Cor pulmonale-late Cor pulmonale-early
 Serum or plasma retinol
 Serum or plasma alpha tocopherol Nutritional Care in Chronic Pulmonary Disease
Goals of Nutritional Therapy
 Albumin
 Electrolytes & acid base status  Maintain acceptable weight for height
 Maintain fluid and acid base balance
Nutritional Problem in CF  Manage drug nutrient interaction
 Pancreatic enzyme insufficiency
 Malabsorption Nutritional Status
↑ Requirement from maldigestion,
1. ↓ HCO3- secretion malabsorption
2. ↓ bile acid reabsorption Complications: cough
3. excessive mucus Retarded growth
GI distress
Symptoms of CF malabsorption Anorexia during infection
 bulky foul-smelling stools Altered smell
 cramping
 obstruction Nutritional Requirements
 rectal prolapse Energy
 liver damage  1.0-1.2 maintenance
 other problems: impaired glucose  1.4-1.6 repletion
tolerance Macronutrient mix
 Do not overfeed!
Nutritional Care Goals  RQ=CO2/O2 CHO=1 fat=0.7
 control malabsorption  Mixed diet=0.87
 provide adequate nutrients for growth Omega 3 FA
 protect smokers from COPD
Common treatment  anti-inflammatory
Vit C supplement for smokers  Positive end expiratory pressure (PEEP)
 16-30 mg/day Nutritional balance important to obtain
 RDA-75mg/day  Muscle strength
 Albumin levels
Treatment  RQ
 Bronchodilator-theophylline &  PO4 depletion corrected
aminophylline
 Antibiotics-secondary infection Nutritional Care for PTB
 Respiratory therapy Goals: maintain weight
 Exercise to strengthen muscles Restore Calcium levels in serum
Categories of Medical Nutrition Therapy Replace losses from lung bleed
 Routine care Promote healing of pulmonary cavities
 Anticipatory guidance: 90% IBW Counteract side effects of Drug
Prevent dehydration
 Supportive intervention: 85-90% IBW
 Resuscitative/palliative: ↓ 75% IBW Summary
 Rehabilitative Care: consistently ↓ 85% Pulmonary
IBW Effect of-nutrition on lungs
Lung status on nutrition
Medical Nutrient Therapy High Metabolic Rate
 Monitor side effects of food Drug Will need-extra kcal
interaction -less from carbohydrates than
 Aminoglycosides ↓ serum Mg++ (need usual
to replace)
 Prednisone-monitor Nitrogen, Ca++,
serum glucose, etc.

Cellular damage
 Causes oxidative stress
 Excessive accumulation of O2 free
radicals (superoxide anions, H2O2,
hydroxyl radicals, singlet molecular O2)
 Cellular injury may lead to SIRS
 Mixed results of trials with antioxidants

Oxidative Stress & Critical Illness


 Mounting evidence exists that oxidative
stress plays a pivotal role in critical
illness
 ↓ antioxidant defenses

Gluthathione—made up of cysteine, glysine,


glutamate

Nutritional Care in Respiratory Failure


Goal of Nutritional therapy
 Meet energy & nutrient requirement
 Preserve LBM
 Maintain fluid & acid base balance
 Provide nutritional substrate that will
not ↑ CO2

Respiratory Failure
 Patient on ventilation
 Benefits from giving antioxidant
 Lab values
pCO2 >50mmHg (35-45 mmHg)
pO2 <60mmHg (80-100mmHg)
pH <7.30 (7.35-7.45)
HCO3- (22-26 mEq/L)
O2 saturation >95% (>95%)

Respiratory Weaning
Information monitored
 Concentration of inspired O2 (FiO2)

Das könnte Ihnen auch gefallen